⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
globenewswire.com
TEVA
WEIFX SECURITIES: Wildermuth Fund Investors with Losses are Reminded to Contact BFA Law by December 29 Securities Fraud Class Action Deadline Ready to Announce with Confidence?
newsfilecorp.com
ARE
BRBR
INSP
TSLA
TEVA
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
globenewswire.com
ALVO
TEVA
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
globenewswire.com
ALVO
TEVA
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
globenewswire.com
ALVO
TEVA
Medincell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote
businesswire.com
TEVA
Respiratory Inhaler Devices Market to Reach $51.9 billion, Globally, by 2034 at 4.8% CAGR: Allied Market Research
prnewswire.com
AZN
BIIB
TEVA
NVS
GSK
SUN
Rapid Growth in Transmucosal Systems Driven by High Bioavailability Benefits
globenewswire.com
AQST
TEVA
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
globenewswire.com
TEVA
Teva Releases Q4 2025 Aide Memoire
globenewswire.com
TEVA